Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchiolitis obliterans

S Sundaresan1

  • 1Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.

Seminars in Thoracic and Cardiovascular Surgery
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Bronchiolitis obliterans syndrome (BOS) significantly impacts long-term lung transplant survival. While immunosuppression can slow graft decline, a cure for BOS remains rare, highlighting the need for novel therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Intrusion of a Liquid Droplet into a Powder under Gravity.

Langmuir : the ACS journal of surfaces and colloids·2016
Same author

Thyroid hormone is required for the pruning of afferent type II spiral ganglion neurons in the mouse cochlea.

Neuroscience·2015
Same journal

A Systematic Review on the Impact of Postoperative Rehabilitation Programs in Thoracic Surgery Patients.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Valved Sano Conduit During the Norwood Procedure: A Contemporary Review of Early Outcomes, Reintervention Burden, and Pulmonary Artery Growth.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Propensity Score-Matched Analysis Comparing Modified Konno Procedure and Transaortic Septal Myectomy in Children With Left Ventricular Outflow Tract Obstruction.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Post-Operative Hemothorax: Uniportal Video-Assisted Thoracic Surgery vs Thoracotomy-Analysis of Outcomes and Costs.

Seminars in thoracic and cardiovascular surgery·2026
Same journal

Palliative Care Throughout the Entire Perioperative Pathway in Cardiovascular Surgery.

Seminars in thoracic and cardiovascular surgery·2026
See all related articles

Area of Science:

  • Pulmonology
  • Transplantation Immunology

Background:

  • Lung transplantation offers high survival rates, but long-term graft function is compromised by bronchiolitis obliterans syndrome (BOS).
  • BOS is a major cause of chronic lung allograft dysfunction, characterized by airflow limitation and immune-mediated rejection.
  • This syndrome affects all types of lung allograft recipients, leading to progressive respiratory debilitation.

Purpose of the Study:

  • To review the clinical presentation, diagnosis, and management of bronchiolitis obliterans syndrome (BOS) after lung transplantation.
  • To discuss the challenges in diagnosing and treating this common complication of lung allografts.
  • To highlight the limited efficacy of current therapeutic strategies and the need for further research.

Main Methods:

  • Review of existing literature and clinical data on lung transplantation outcomes and BOS.

Related Experiment Videos

  • Analysis of diagnostic criteria and staging systems for BOS.
  • Evaluation of treatment strategies, including immunosuppression augmentation and re-transplantation.

    • Main Results:

    • Hospital survival post-lung transplant exceeds 90%, but actuarial freedom from BOS at 5 years is only 29%.
    • BOS is characterized by progressive airflow limitation, often indicating chronic lung allograft rejection.
    • Current treatments, primarily increased immunosuppression, offer limited success in halting BOS progression, with re-transplantation being a rare option.

    Conclusions:

    • Bronchiolitis obliterans syndrome (BOS) remains a significant challenge in long-term lung allograft survival.
    • Effective treatments for BOS are lacking, necessitating the development of new therapeutic approaches.
    • Early diagnosis and management are crucial, but achieving a cure for BOS is exceptionally rare.